Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Volitionrx Limited (VNRX)  
$0.71 0.03 (4.89%) as of 4:30 Fri 6/14


Download
   
Exchange: OTC Bulletin Board
Security Type: N/A
Shares Out: 26,519,000
Market Cap: 18.78(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.55 - $1.72
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   VolitionRx is an epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 10,000 200,422 928,911
Total Buy Value $0 $8,300 $194,762 $1,588,869
Total People Bought 0 1 11 12
Total Buy Transactions 0 1 20 37
Total Shares Sold 0 20,000 40,000 40,000
Total Sell Value $0 $18,000 $33,000 $33,000
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 2 2
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 321
  Page 12 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Skaff Habib Director   –       •      –    2016-05-20 4 OE $3.00 $12,000 D/D 4,000 18,580     -
   Rootsaert Rodney Gerard Secretary   •       –      –    2016-05-20 4 D $3.54 $30,002 D/D (8,475) 1,525     -
   Rootsaert Rodney Gerard Secretary   •       –      –    2016-05-20 4 OE $3.00 $30,000 D/D 10,000 10,000     -
   Innes Guy Archibald Director   –       •      –    2016-05-20 4 D $3.54 $15,003 D/D (4,238) 1,228,503     -
   Innes Guy Archibald Director   –       •      –    2016-05-20 4 OE $3.00 $15,000 D/D 5,000 1,232,741     -
   Reynolds Cameron John President and CEO   •       •      –    2016-05-20 4 S $3.54 $12,001 I/I (3,390) 28,897     -
   Reynolds Cameron John President and CEO   •       •      –    2016-05-20 4 OE $3.00 $12,000 I/I 4,000 32,287     -
   Reynolds Cameron John President and CEO   •       •      –    2016-05-20 4 D $3.54 $60,003 D/D (16,950) 1,108,066     -
   Reynolds Cameron John President and CEO   •       •      –    2016-05-20 4 OE $3.00 $60,000 D/D 20,000 1,125,016     -
   Colman Alan Director   –       •      –    2016-05-20 4 D $3.54 $15,003 D/D (4,238) 154,699     -
   Colman Alan Director   –       •      –    2016-05-20 4 OE $3.00 $15,000 D/D 5,000 158,937     -
   Micallef Jacob Vincent Chief Scientific Officer   •       –      –    2016-05-20 4 D $3.54 $60,003 I/I (16,950) 31,506     -
   Micallef Jacob Vincent Chief Scientific Officer   •       –      –    2016-05-20 4 OE $3.00 $60,000 I/I 20,000 48,456     -
   Reynolds Cameron John President and CEO   •       •      –    2016-04-20 4/A OE $2.60 $3,047 D/D 1,172 1,105,016     -
   Reynolds Cameron John President and CEO   •       •      –    2016-04-20 4 OE $2.60 $3,715 I/I 1,429 28,287     -
   Reynolds Cameron John President and CEO   •       •      –    2016-04-20 4 OE $2.60 $3,047 D/D 1,172 1,103,844     -
   Colman Alan Director   –       •      –    2016-03-29 4 OE $0.50 $50,000 D/D 100,000 153,937     -
   Innes Guy Archibald Director   –       •      –    2016-03-22 4 OE $0.50 $50,000 D/D 100,000 1,270,197     -
   Terrell Jason Bradley Md Chief Medical OfficerOfficer   •       –      –    2016-01-01 3 IO $0.00 $0 D/D 0 61,364     -
   Faulkes Martin Charles Director   –       •      –    2015-12-14 4 OE $1.05 $262,500 D/D 250,000 1,291,067     -
   Micallef Jacob Vincent Chief Scientific Officer   •       –      –    2015-12-09 4 D $4.20 $150,503 I/I (35,834) 28,456     -
   Micallef Jacob Vincent Chief Scientific Officer   •       –      –    2015-12-09 4 OE $3.01 $150,500 I/I 50,000 64,290     -
   Micallef Jacob Vincent Chief Scientific OfficerOffice   •       –      –    2015-08-18 3 IO $0.00 $0 I/I 0 14,290     -
   Micallef Jacob Vincent Chief Scientific OfficerOffice   •       –      –    2015-08-18 3 IO $0.00 $0 D/D 0 86,166     -
   Reynolds Cameron John President and CEO   •       •       •   2015-05-15 4 B $3.32 $4,989 D/D 1,500 1,103,844 3.15     -

  321 Records found
  Previous  10  11  12  13   
  Page 12 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed